Department of Liver Transplant, Tianjin First Central Hospital, Tianjin 300192, China.
World J Gastroenterol. 2017 Dec 7;23(45):8104-8108. doi: 10.3748/wjg.v23.i45.8104.
Simultaneous liver, pancreas-duodenum, and kidney transplantation has been rarely reported in the literature. Here we present a new and more efficient technique that combines classic orthotopic liver and pancreas-duodenum transplantation and heterotopic kidney transplantation for a male patient aged 44 years who had hepatitis B related cirrhosis, renal failure, and insulin dependent diabetes mellitus (IDDM). A quadruple immunosuppressive regimen including induction with basiliximab and maintenance therapy with tacrolimus, mycophenolate mofetil, and steroids was used in the early stage post-transplant. Postoperative recovery was uneventful and the patient was discharged on the 15 postoperative day with normal liver and kidney function. The insulin treatment was completely withdrawn 3 wk after operation, and the blood glucose level remained normal. The case findings support that abdominal organ cluster and kidney transplantation is an effective method for the treatment of end-stage liver disease combined with uremia and IDDM.
文献中鲜有同时进行肝、胰十二指肠和肾联合移植的报道。我们在此提出一种新的、更有效的技术,将经典的原位肝和胰十二指肠联合移植与异位肾移植相结合,应用于一位 44 岁男性患者,该患者患有乙型肝炎相关肝硬化、肾衰竭和胰岛素依赖型糖尿病(IDDM)。在移植后的早期阶段,使用了包括巴利昔单抗诱导和他克莫司、霉酚酸酯和类固醇维持治疗的四重免疫抑制方案。术后恢复顺利,患者在术后第 15 天出院,肝肾功能正常。术后 3 周停用胰岛素治疗,血糖水平保持正常。该病例结果支持腹部器官簇和肾联合移植是治疗终末期肝病合并尿毒症和 IDDM 的有效方法。